journal article·2017-03-14Open access

Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity

Daniel A. Sheik, Jeffrey M. Chamberlain, Lauren Brooks, Melissa Clark, Young Hun Kim, Geoffray Leriche, Clifford P. Kubiak, Stephen Dewhurst, Jerry Yang

Langmuir· Volume 33· Issue 10

Abstract

Semen-derived enhancer of virus infection (SEVI) fibrils are naturally abundant amyloid aggregates found in semen that facilitate viral attachment and internalization of human immunodeficiency virus (HIV) in cells, thereby increasing the probability of infection. Mature SEVI fibrils are composed of aggregated peptides exhibiting high β-sheet secondary structural characteristics. Herein, we show that polymers containing hydrophobic side chains can interact with SEVI and reduce its β-sheet content by ∼45% compared with the β-sheet content of SEVI in the presence of polymers with hydrophilic side chains, as estimated by polarization modulation-infrared reflectance absorption spectroscopy measurements. A nanoparticle (NP) formulation of this hydrophobic polymer reduced SEVI-mediated HIV infection in TMZ-bl cells by 60% compared with the control treatment. Although these NPs lacked specific amyloid-targeting groups, thus requiring high concentrations to observe biological activity, the use of hydrophobic interactions to alter the secondary structure of amyloids represents a useful approach to neutralizing the SEVI function. These results could, therefore, have general implications in the design of novel materials that can modify the activity of amyloids associated with a variety of other neurological and systemic diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Alzheimer's disease research and treatments · HIV Research and Treatment · Prion Diseases and Protein Misfolding

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, United States

Department of Microbiology and Immunology, University of Rochester, Rochester, New York 14642, United States

Funding

California HIV/AIDS Research Program · National Institute of Allergy and Infectious Diseases

References (60)

Show source-provided references
1. 10.1056/nejm19970410336150710.1056/nejm199704103361507 ↗
2. 10.1038/nrmicro79410.1038/nrmicro794 ↗
3. 10.1016/j.cell.2007.10.01410.1016/j.cell.2007.10.014 ↗
4. 10.1016/j.chom.2011.10.01010.1016/j.chom.2011.10.010 ↗
5. 10.1128/jvi.06121-1110.1128/jvi.06121-11 ↗
6. 10.1128/jvi.01366-0810.1128/jvi.01366-08 ↗
7. 10.1128/aac.02464-1210.1128/aac.02464-12 ↗
8. 10.1016/j.bpj.2009.08.03410.1016/j.bpj.2009.08.034 ↗
9. 10.7717/peerj.510.7717/peerj.5 ↗
10. 10.1074/jbc.m111.31433610.1074/jbc.m111.314336 ↗
11. 10.1016/j.bmcl.2013.06.09710.1016/j.bmcl.2013.06.097 ↗
12. 10.1016/j.bpj.2011.01.03710.1016/j.bpj.2011.01.037 ↗
13. 10.1074/jbc.m109.06616710.1074/jbc.m109.066167 ↗
14. 10.1186/1742-6405-9-210.1186/1742-6405-9-2 ↗
15. 10.1073/pnas.081182710610.1073/pnas.0811827106 ↗
16. 10.1097/qad.000000000000030810.1097/qad.0000000000000308 ↗
17. 10.1016/j.bpobgyn.2012.01.01010.1016/j.bpobgyn.2012.01.010 ↗
18. 10.3390/biology101005810.3390/biology1010058 ↗
19. 10.1021/jp212157710.1021/jp2121577 ↗
20. 10.1074/jbc.m110.16365910.1074/jbc.m110.163659 ↗
21. 10.1021/ja210931b10.1021/ja210931b ↗
22. 10.1021/nn506725410.1021/nn5067254 ↗
23. 10.1016/j.bmcl.2005.10.06710.1016/j.bmcl.2005.10.067 ↗
24. 10.1002/cbic.20060011910.1002/cbic.200600119 ↗
25. 10.1016/s0925-4439(00)00029-610.1016/s0925-4439(00)00029-6 ↗
26. 10.1016/s0006-3495(03)74550-010.1016/s0006-3495(03)74550-0 ↗
27. 10.1074/jbc.274.36.2594510.1074/jbc.274.36.25945 ↗
28. 10.1006/jmbi.2000.390810.1006/jmbi.2000.3908 ↗
29. 10.1038/nature0226410.1038/nature02264 ↗
30. 10.4161/pri.2.3.748810.4161/pri.2.3.7488 ↗
31. 10.1073/pnas.050672310210.1073/pnas.0506723102 ↗
32. 10.1021/ja908170s10.1021/ja908170s ↗
33. 10.1073/pnas.96.18.998910.1073/pnas.96.18.9989 ↗
34. 10.1126/science.156606710.1126/science.1566067 ↗
35. 10.1021/ac203085910.1021/ac2030859 ↗
36. 10.1002/mabi.20040018910.1002/mabi.200400189 ↗
37. 10.1371/journal.pone.002595410.1371/journal.pone.0025954 ↗
38. 10.1021/bm301117710.1021/bm3011177 ↗
39. 10.1021/cn300205g10.1021/cn300205g ↗
40. 10.1002/anie.20100782410.1002/anie.201007824 ↗
41. 10.1002/app.2834810.1002/app.28348 ↗
42. 10.1073/pnas.060175510310.1073/pnas.0601755103 ↗
43. 10.1016/j.progpolymsci.2011.01.00110.1016/j.progpolymsci.2011.01.001 ↗
44. 10.1016/s0378-5173(02)00315-010.1016/s0378-5173(02)00315-0 ↗
45. 10.1016/j.biomaterials.2004.07.05010.1016/j.biomaterials.2004.07.050 ↗
46. 10.1002/pen.1037310.1002/pen.10373 ↗
47. 10.1038/nprot.2006.20210.1038/nprot.2006.202 ↗
48. 10.1016/j.bbapap.2014.06.00610.1016/j.bbapap.2014.06.006 ↗
49. 10.2307/268526310.2307/2685263 ↗
50. 10.1002/cyto.a.2089610.1002/cyto.a.20896 ↗
51. 10.1021/ac702592f10.1021/ac702592f ↗
52. 10.1074/jbc.c30004920010.1074/jbc.c300049200 ↗
53. 10.1163/156856193x0082610.1163/156856193x00826 ↗
54. 10.1021/bi980096y10.1021/bi980096y ↗
55. 10.1073/pnas.030717810110.1073/pnas.0307178101 ↗
56. 10.1126/science.109018710.1126/science.1090187 ↗
57. 10.1038/nature0145710.1038/nature01457 ↗
58. 10.1021/bi00465a02210.1021/bi00465a022 ↗
59. 10.1038/nprot.2015.02410.1038/nprot.2015.024 ↗
60. 10.1002/bip.36025030710.1002/bip.360250307 ↗